Altaris Capital Partners Majority Recapitalizes Minnetronix Medical

Altaris Capital Partners Acquires Meridian Medical Technologies from Pfizer

December 30, 2021

Medical Devices

Altaris Capital Partners has entered into an agreement to acquire Meridian Medical Technologies from Pfizer. Meridian, a pioneer in emergency response drug-device combination products and auto-injectors with facilities in St. Louis, Missouri and Columbia, Maryland and more than 750 employees, will become an Altaris portfolio company to expand the firm's capabilities in medical countermeasures and emergency response solutions.

Altaris Capital Partners Acquires Intricon Corporation

May 24, 2022

Medical Devices

Altaris Capital Partners completed the acquisition of Intricon Corporation, taking the NASDAQ-listed micromedical contract developer and manufacturer private for $24.25 per share (approximately $241 million fully diluted). The deal will support Intricon’s continued development and scaling of miniature and micromedical components, sub-assemblies and devices for OEM customers across multiple production facilities in the United States and Asia.

Altaris Acquires Minaris Regenerative Medicine from Resonac

September 23, 2024

Healthcare Services

Altaris, LLC has acquired Minaris Regenerative Medicine from Resonac Corporation, making Minaris a wholly owned portfolio company of Altaris. Minaris is a cell therapy CDMO with six facilities across the United States, Germany and Japan and more than 500 employees; the deal advances Altaris' strategic initiative to build capabilities in cell and gene therapy manufacturing.

Altaris Acquires 51% Stake in Solesis from Michelin

June 1, 2021

Medical Devices

Altaris Capital Partners has completed the acquisition of a 51% stake in Solesis from Michelin, with Michelin retaining a 49% ownership interest and partnering with Altaris to build Solesis as an independent company. Solesis, a U.S.-based biomaterials and medical-device components manufacturer operating through The Secant Group, Charter Medical and SanaVita Medical, employs approximately 360 people across production facilities in Pennsylvania and North Carolina.

Altaris and Investor Group Recapitalize CSafe Global; Frazier Healthcare Partners Among New Investors

October 6, 2016

Manufacturing

Altaris Capital Partners announced a recapitalization of CSafe Global with an investor group that includes funds managed by Frazier Healthcare Partners; Altaris will retain a minority stake. CSafe Global, headquartered in Monroe, Ohio, is a provider of active and passive cold-chain packaging solutions serving the biopharmaceutical industry and will use the transaction to support continued growth and capability expansion.

Altaris Capital Partners Acquires Kindeva Drug Delivery from 3M

May 1, 2020

Medical Devices

Altaris Capital Partners has acquired Kindeva Drug Delivery L.P. (formerly 3M Drug Delivery Systems) from 3M Company for $650 million in a corporate carve-out transaction. Monroe Capital provided financing and an equity co-investment to support the deal, and 3M will retain a minority interest alongside Altaris as Kindeva operates independently to pursue growth and capital investments.